Enliven Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enliven Therapeutics by Baker Bros. Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.0M | 115k | 17.59 |